Kloess, S., Ede Valverde da Silva, A., Oberschmidt, O., Gardlowski, T., Matthies, N., Vyas, M., . . . Köhl, U. (2018). Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset. Front Immunol.
シカゴスタイル引用形Kloess, Stephan, et al. "Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset." Front Immunol 2018.
MLA引用形式Kloess, Stephan, et al. "Corrigendum: Triplebody Mediates Increased Anti-Leukemic Reactivity of IL-2 Activated Donor Natural Killer (NK) Cells and Impairs Viability of Their CD33-Expressing NK Subset." Front Immunol 2018.